OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update

Provided By GlobeNewswire

Last update: Nov 14, 2023

ROCKVILLE, Md., Nov. 14, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported its third quarter 2023 financial and operating results.